JUSHF
Price
$0.59
Change
-$0.07 (-10.61%)
Updated
Aug 15 closing price
Capitalization
115.84M
93 days until earnings call
KHTRF
Price
$4.66
Change
+$0.11 (+2.42%)
Updated
Aug 7 closing price
Capitalization
450.67M
Interact to see
Advertisement

JUSHF vs KHTRF

Header iconJUSHF vs KHTRF Comparison
Open Charts JUSHF vs KHTRFBanner chart's image
Jushi Holdings
Price$0.59
Change-$0.07 (-10.61%)
Volume$909.44K
Capitalization115.84M
Knight Therapeutics
Price$4.66
Change+$0.11 (+2.42%)
Volume$520
Capitalization450.67M
JUSHF vs KHTRF Comparison Chart in %
Loading...
JUSHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KHTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JUSHF vs. KHTRF commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JUSHF is a Hold and KHTRF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (JUSHF: $0.59 vs. KHTRF: $4.66)
Brand notoriety: JUSHF and KHTRF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: JUSHF: 262% vs. KHTRF: 19%
Market capitalization -- JUSHF: $115.84M vs. KHTRF: $450.67M
JUSHF [@Pharmaceuticals: Generic] is valued at $115.84M. KHTRF’s [@Pharmaceuticals: Generic] market capitalization is $450.67M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JUSHF’s FA Score shows that 0 FA rating(s) are green whileKHTRF’s FA Score has 0 green FA rating(s).

  • JUSHF’s FA Score: 0 green, 5 red.
  • KHTRF’s FA Score: 0 green, 5 red.
According to our system of comparison, JUSHF is a better buy in the long-term than KHTRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JUSHF’s TA Score shows that 5 TA indicator(s) are bullish while KHTRF’s TA Score has 4 bullish TA indicator(s).

  • JUSHF’s TA Score: 5 bullish, 5 bearish.
  • KHTRF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both JUSHF and KHTRF are a good buy in the short-term.

Price Growth

JUSHF (@Pharmaceuticals: Generic) experienced а -13.08% price change this week, while KHTRF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

Reported Earning Dates

JUSHF is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KHTRF($451M) has a higher market cap than JUSHF($116M). JUSHF YTD gains are higher at: 89.193 vs. KHTRF (29.086). KHTRF has higher annual earnings (EBITDA): 69.3M vs. JUSHF (53M). KHTRF has more cash in the bank: 181M vs. JUSHF (26M). KHTRF has less debt than JUSHF: KHTRF (53.9M) vs JUSHF (264M). KHTRF has higher revenues than JUSHF: KHTRF (373M) vs JUSHF (256M).
JUSHFKHTRFJUSHF / KHTRF
Capitalization116M451M26%
EBITDA53M69.3M76%
Gain YTD89.19329.086307%
P/E RatioN/A62.66-
Revenue256M373M69%
Total Cash26M181M14%
Total Debt264M53.9M490%
FUNDAMENTALS RATINGS
JUSHF vs KHTRF: Fundamental Ratings
JUSHF
KHTRF
OUTLOOK RATING
1..100
1432
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
72
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9990
PRICE GROWTH RATING
1..100
3549
P/E GROWTH RATING
1..100
10096
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

JUSHF's Valuation (50) in the null industry is in the same range as KHTRF (72). This means that JUSHF’s stock grew similarly to KHTRF’s over the last 12 months.

JUSHF's Profit vs Risk Rating (100) in the null industry is in the same range as KHTRF (100). This means that JUSHF’s stock grew similarly to KHTRF’s over the last 12 months.

KHTRF's SMR Rating (90) in the null industry is in the same range as JUSHF (99). This means that KHTRF’s stock grew similarly to JUSHF’s over the last 12 months.

JUSHF's Price Growth Rating (35) in the null industry is in the same range as KHTRF (49). This means that JUSHF’s stock grew similarly to KHTRF’s over the last 12 months.

KHTRF's P/E Growth Rating (96) in the null industry is in the same range as JUSHF (100). This means that KHTRF’s stock grew similarly to JUSHF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
JUSHFKHTRF
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
55%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
48%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 7 days ago
46%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
47%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
35%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
39%
Advances
ODDS (%)
Bullish Trend 7 days ago
88%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
49%
Aroon
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
37%
View a ticker or compare two or three
Interact to see
Advertisement
JUSHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KHTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCEBX9.850.20
+2.07%
Goldman Sachs Clean Energy Income A
NMGAX18.750.03
+0.16%
Neuberger Berman Mid Cap Growth A
PPQJX3.64N/A
N/A
Principal MidCap Growth III J
OCSGX7.00-0.01
-0.14%
Optimum Small-Mid Cap Growth C
VSEQX38.76-0.13
-0.33%
Vanguard Strategic Equity Inv

JUSHF and

Correlation & Price change

A.I.dvisor tells us that JUSHF and KHTRF have been poorly correlated (+13% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JUSHF and KHTRF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JUSHF
1D Price
Change %
JUSHF100%
-10.65%
KHTRF - JUSHF
13%
Poorly correlated
N/A
HYPMY - JUSHF
8%
Poorly correlated
+4.58%
IPSEF - JUSHF
8%
Poorly correlated
N/A
HSTI - JUSHF
8%
Poorly correlated
N/A
MCUJF - JUSHF
7%
Poorly correlated
N/A
More

KHTRF and

Correlation & Price change

A.I.dvisor tells us that KHTRF and ESALF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KHTRF and ESALF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KHTRF
1D Price
Change %
KHTRF100%
N/A
ESALF - KHTRF
27%
Poorly correlated
+0.32%
OVATF - KHTRF
25%
Poorly correlated
N/A
TAK - KHTRF
22%
Poorly correlated
+1.35%
JUSHF - KHTRF
13%
Poorly correlated
-10.65%
HYPMY - KHTRF
8%
Poorly correlated
+4.58%
More